IRD vs OKE · rev $11.0M vs P/E 15, rev $21.70B
Opus Genetics, Inc. (IRD) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
IRD currently screens at market cap $35.7M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the IRD and OKE stock pages for the full models.
Not investment advice.